E-LIB Suche - Ergebnisse für: Monk, Bradley J

1

Health-related quality of life in patients with newly diagn..:

Pothuri, Bhavana ; Han, Sileny ; Chase, Dana M....
Gynecologic Oncology. 184 (2024) - p. 168-177 , 2024

Link: https://doi.org/10.1016/..

2

Cytochrome P450 inhibitor/inducer treatment patterns among ..:

Rimel, Bobbie J. ; Chase, Dana M. ; Perhanidis, Jessica...
Gynecologic Oncology Reports. 51 (2024) - p. 101332 , 2024

Link: https://doi.org/10.1016/..

3

Immunotherapy plus chemoradiotherapy in cervical cancer man..:

Tewari, Krishnansu S ; Monk, Bradley J
The Lancet. 403 (2024) 10434 - p. 1310-1311 , 2024

Link: https://doi.org/10.1016/..

4

Preoperative and pre-chemotherapy CA-125 levels in high-ris..:

Chan, John K. ; Tian, Chunqiao ; Kesterson, Joshua P....
Gynecologic Oncology. 181 (2024) - p. 54-59 , 2024

Link: https://doi.org/10.1016/..

5

CALLA trial: immunotherapy in locally advanced cervical can..:

Monk, Bradley J ; Mayadev, Jyoti
The Lancet Oncology. 25 (2024) 3 - p. e96 , 2024

Link: https://doi.org/10.1016/..

6

Paclitaxel therapeutic drug monitoring - International asso..:

Hertz, Daniel L. ; Joerger, Markus ; Bang, Yung-Jue...
European Journal of Cancer. 202 (2024) - p. 114024 , 2024

Link: https://doi.org/10.1016/..

7

Progression-free survival and safety at 3.5 years of follow..:

González-Martín, Antonio ; Pothuri, Bhavana ; Vergote, Ignace...
Future Oncology. , 2024

Link: https://doi.org/10.2217/..

8

A systematic review of stage IVA cervical cancer treatment:..:

Hunsberger, Kyra S. ; Treiman, Sierra ; Monk, Bradley J....
Gynecologic Oncology. 187 (2024) - p. 120-127 , 2024

Link: https://doi.org/10.1016/..

9

ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized,..:

Vergote, Ignace ; Perez Fidalgo, Alejandro ; Valabrega, Giorgio...
International Journal of Gynecologic Cancer. , 2024

Link: https://doi.org/10.1136/..

10

A plain language summary of publication of the efficacy and..:

Mirza, Mansoor R ; González-Martín, Antonio ; Graybill, Whitney S...
Future Oncology. 20 (2024) 13 - p. 799-809 , 2024

Link: https://doi.org/10.2217/..

11

Evolving treatment paradigms in metastatic or recurrent low..:

Mahdi, Haider ; Ray-Coquard, Isabelle ; Lorusso, Domenica...
International Journal of Gynecologic Cancer. 33 (2023) 11 - p. 1675-1681 , 2023

Link: https://doi.org/10.1136/..

12

Durvalumab versus placebo with chemoradiotherapy for locall..:

Monk, Bradley J ; Toita, Takafumi ; Wu, Xiaohua...
The Lancet Oncology. 24 (2023) 12 - p. 1334-1348 , 2023

Link: https://doi.org/10.1016/..

13

The promise of combining CDK4/6 inhibition with hormonal th..:

Ray-Coquard, Isabelle ; Monk, Bradley J ; Lorusso, Domenica...
International Journal of Gynecologic Cancer. 33 (2023) 12 - p. 1943-1949 , 2023

Link: https://doi.org/10.1136/..

14

Progression-free survival and safety at 3.5 years of follow..:

González-Martín, Antonio ; Pothuri, Bhavana ; Vergote, Ignace...
European Journal of Cancer. 189 (2023) - p. 112908 , 2023

Link: https://doi.org/10.1016/..

15

Final survival analysis of topotecan and paclitaxel for fir..:

Tewari, Krishnansu S. ; Sill, Michael W. ; Birrer, Michael J....
Gynecologic Oncology. 171 (2023) - p. 141-150 , 2023

Link: https://doi.org/10.1016/..